2010 Compounding Vaccines 
Pharmacy Times
JULY 25, 2025
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi:10.1093/cid/ciu444. Clin Infect Dis.
Drug Topics
JUNE 25, 2025
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 18, 2025
Sweden’s move from the 13-valent pneumococcal conjugate vaccine (PCV13) to PCV10 in 2019 is most likely responsible for the uptick in pHUS cases because of changes in serotype coverage. 1 “In Sweden, PCV13 was introduced in the NIP in 2010 but replaced by PCV10 in 2019.” coli, the remaining 10% is almost entirely caused by S.
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al.
Pharmaceutical Technology
APRIL 18, 2023
Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.
ISPE
MARCH 8, 2023
5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. million vials, 26 had to be recalled and destroyed.
Expert insights. Personalized for you.
Let's personalize your content